We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SDR:LSESchroders PLC Analysis

Data as of 2026-07-29 - not real-time

£588.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Schroders plc sits in a bullish technical environment, with price trading above its short‑term moving averages and a modest upward momentum indicator. However, the MACD histogram has turned slightly negative and trading volume is on a downtrend, hinting at a possible short‑term pullback toward the identified support zone.
Fundamentally, the firm delivers robust profitability—high gross and operating margins—paired with solid cash generation and a dividend yield that tops 3.5%. The payout ratio remains below 70%, supporting dividend sustainability. Valuation metrics are mixed: while the price‑to‑earnings ratio aligns closely with the industry average, the discounted cash‑flow model suggests the market price may be modestly above intrinsic value, and the downside‑adjusted upside is negative. The market sentiment is extremely bullish, as reflected by a high fear‑and‑greed index, which could amplify short‑term price pressure.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price approaching short‑term resistance while MACD shows a bearish crossover
  • Decreasing trading volume indicating waning momentum
  • Support level provides a cushion against immediate downside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and high profitability margins
  • Sustainable dividend with ample cash flow coverage
  • Neutral beta and low volatility reduce market‑wide risk exposure

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Consistent dividend policy supports income‑focused investors
  • Diversified global asset‑management platform mitigates geographic concentration
  • Regulatory environment for asset managers remains stable, limiting systemic risk

Key Metrics & Analysis

Financial Health

Revenue Growth15.50%
Profit Margin15.81%
P/E Ratio17.3
ROE12.30%
ROA2.29%
Debt/Equity12.87
P/B Ratio2.1
Op. Cash Flow£914.4M
Free Cash Flow£1.2B
Industry P/E18.1

Technical Analysis

TrendBullish
RSI62.1
Support£578.50
Resistance£599.00
MA 20£587.53
MA 50£585.43
MA 200£508.90
MACDBearish
VolumeDecreasing
Fear & Greed Index86.86

Valuation

Fair Value£2,245.33
Target Price£542.41
Upside/Downside-7.83%
GradeOvervalued
TypeBlend
Dividend Yield3.65%

Risk Assessment

Beta-0.11
Volatility2.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.